Why the study?
Do drug-eluting stents reduce target-vessel revascularization compared to bare-metal stents in patients undergoing primary percutaneous coronary intervention for STEMI?
Population
6,298 patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary…
Comparison
Drug-eluting stents vs Bare-metal stents (BMS)
Design
Meta-analysis
Follow-up
mean 1201 days (SD 440)
Authors
Loading...
Supports DES over BMS to cut revascularization in STEMI PCI; confirms Level 1 meta-analytic evidence.
Do drug-eluting stents reduce target-vessel revascularization compared to bare-metal stents in patients undergoing primary percutaneous coronary intervention for STEMI?
In patients with STEMI undergoing primary PCI, early-generation drug-eluting stents significantly reduce long-term target-vessel revascularization compared to bare-metal stents, though they carry an increased risk of very late stent thrombosis and reinfarction.
Luca et al. (2012) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: